How a Duke Professor and Two Duke Ph.D.s are Building an AI Drug Discovery Start-Up — Duke OTC

Duke Professor Bruce Donald and his former students are combining computer science, structural biology, and an entrepreneurial spirit to design new drugs at Ten63 Therapeutics.

Related Keywords

California ,United States ,San Francisco ,Russia ,Alexandria ,Al Iskandariyah ,Egypt ,Stanford University ,Russian ,Fedor Kossakovski ,Marcel Frenkel ,Harvard Robinson Hall ,Donald Duke ,Mark Hallen ,Dinesh Divakaran ,Patrick Winston ,Bruce Donald ,Paul Allen ,Microsoft ,Duke Biochemistry Department ,Duke University Professor Bruce Donald ,Interval Research Corporation ,Brooks Brothers ,Duke University Office For Translation Commercialization ,Yale University ,Duke University ,Sigma Group ,Cornell University ,Harvard Laboratory For Computer Graphics ,Draper Associates ,Dartmouth College ,Duke Professor ,Duke Capital Partners ,Massachusetts Institute ,Artificial Intelligence ,Professor Patrick ,Harvard Laboratory ,Computer Graphics ,Geographic Information System ,Robinson Hall ,Computer Science ,Digital Innovations ,Duke University Office ,Bay Area ,Venture Partners ,Morpheus Ventures ,Alexandria Venture Investments ,Downtown Durham ,